NL-OMON24043招募中不适用
Patient informed choice between palliative chemotherapy and best supportive care.
P.Stalmeier, N. Ottevanger, P. de Mulder0 个研究点目标入组 170 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 170
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with distant metastases or loco-regional recurrence after primary breast, colon, or ovarian cancer are eligible, if they are treated or have been treated with first line palliative chemotherapy.
排除标准
- •Exclusion criteria are labile personality structure, as assessed by the physicians, and a Karnofsky lower than 60.
研究者
相似试验
尚未招募
不适用
Patient informed choice between palliative chemotherapy and best supportive care: who wants it?NL-OMON30246niversitair Medisch Centrum Sint Radboud170
招募中
不适用
Patient preference to guide AFO prescriptioNL-OMON28247Sint Maartenskliniek25
撤回
不适用
Influence of Patient-Informed Choice in a Novel Treatment Model for LBPMechanical Low Back PainNCT01744015Walsh University
已完成
不适用
Patient participation in end-of-life-decision-makingdialyserenNephrologie1002765510029149NL-OMON38049Vrije Universiteit Medisch Centrum45
已完成
不适用
Patient Satisfaction With the Management of a Stopped Pregnancy in the First TrimesterPregnancy Loss, EarlyNCT05049980University Hospital, Toulouse52
